B. Lisboa
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 2
- Protease and Inhibitor Mechanisms 2
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Co-authors
- Thomas Löning (3 shared papers)Karin Milde‐Langosch (3 shared papers)Lutz Riethdorf (2 shared papers)Christoph Thomssen (5 shared papers)Michael Untch (6 shared papers)R.W. Blamey (1 shared paper)Matthias Geberth (1 shared paper)Jack Cuzick (1 shared paper)
- Journals
- RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (3 papers)European Journal of Cancer (2 papers)The International Journal of Biological Markers (2 papers)Journal of Histochemistry & Cytochemistry (1 paper)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1 paper)
- Partner nations
- GermanyNetherlandsSlovenia
In The Last Decade
B. Lisboa
20 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 76
- Cancer Research 664
- Oncology 579
- Immunology and Allergy 128
- Genetics 207
- Hematology 72
Countries citing papers authored by B. Lisboa
This map shows the geographic impact of B. Lisboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lisboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lisboa more than expected).
Fields of papers citing papers by B. Lisboa
This network shows the impact of papers produced by B. Lisboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lisboa. The network helps show where B. Lisboa may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Lisboa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 497 | |
| 2 | 2002 | 269 | |
| 3 | 2013 | 132 | |
| 4 | 1997 | 93 | |
| 5 | 1999 | 86 | |
| 6 | 2008 | 58 | |
| 7 | 2014 | 49 | |
| 8 | 1968 | 32 | |
| 9 | 1997 | 23 | |
| 10 | Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. | 1996 | 23 |
| 11 | Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer. | 1997 | 21 |
| 12 | 2000 | 21 | |
| 13 | Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin. | 1998 | 14 |
| 14 | 2000 | 13 | |
| 15 | 2005 | 8 | |
| 16 | 2003 | 5 | |
| 17 | 2012 | 3 | |
| 18 | 2002 | 3 | |
| 19 | 1997 | 2 | |
| 20 | 1996 | 1 |
About B. Lisboa
B. Lisboa is a scholar working on Cancer Research, Oncology, Cardiology and Cardiovascular Medicine, Immunology and Allergy and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cancer Treatment and Pharmacology (4 papers), Breast Lesions and Carcinomas (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (664 citations), Oncology (579 citations), Immunology and Allergy (128 citations), Genetics (207 citations) and Hematology (72 citations). B. Lisboa has collaborated with scholars based in Germany, Netherlands and Slovenia. Frequent co-authors include Thomas Löning, Karin Milde‐Langosch, Lutz Riethdorf, Christoph Thomssen, Michael Untch, R.W. Blamey, Matthias Geberth, Jack Cuzick, Martin Christian Schumacher and Ilana Fogelman. Their work appears in journals such as RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, European Journal of Cancer, The International Journal of Biological Markers, Journal of Histochemistry & Cytochemistry and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.